Lifeist Wellness Inc. (LFST.V)
CAD 0.05
(-10.0%)
CAD 0.05
(-10.0%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -188.12 Thousand CAD | 94.58% |
| 2022 | -3.47 Million CAD | 71.49% |
| 2021 | -12.18 Million CAD | -27.96% |
| 2020 | -9.52 Million CAD | 74.83% |
| 2019 | -37.83 Million CAD | -10.12% |
| 2018 | -34.35 Million CAD | -4463.89% |
| 2017 | -752.84 Thousand CAD | -1210.23% |
| 2016 | -57.45 Thousand CAD | 65.94% |
| 2015 | -168.69 Thousand CAD | -822.56% |
| 2014 | -18.28 Thousand CAD | 89.11% |
| 2013 | -167.86 Thousand CAD | 45.28% |
| 2012 | -306.79 Thousand CAD | 59.81% |
| 2011 | -763.3 Thousand CAD | -43.84% |
| 2010 | -530.68 Thousand CAD | -78.61% |
| 2009 | -297.11 Thousand CAD | -432.16% |
| 2008 | -55.83 Thousand CAD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | -969.58 Thousand CAD | -104.88% |
| 2024 Q1 | -473.24 Thousand CAD | -151.55% |
| 2024 Q3 | -915.77 Thousand CAD | 29.16% |
| 2023 Q2 | -1.47 Million CAD | -0.39% |
| 2023 Q4 | -188.12 Thousand CAD | 71.62% |
| 2023 Q3 | -662.94 Thousand CAD | 55.01% |
| 2023 FY | -188.12 Thousand CAD | 94.58% |
| 2023 Q1 | -1.46 Million CAD | 57.75% |
| 2022 Q3 | -3.21 Million CAD | 47.56% |
| 2022 FY | -3.47 Million CAD | 71.49% |
| 2022 Q1 | -8.68 Million CAD | 28.74% |
| 2022 Q4 | -3.47 Million CAD | -7.96% |
| 2022 Q2 | -6.13 Million CAD | 29.34% |
| 2021 Q1 | -28.14 Million CAD | -195.52% |
| 2021 Q3 | -17.33 Million CAD | 22.35% |
| 2021 FY | -12.18 Million CAD | -27.96% |
| 2021 Q2 | -22.32 Million CAD | 20.65% |
| 2021 Q4 | -12.18 Million CAD | 29.73% |
| 2020 Q1 | -26.1 Million CAD | 31.0% |
| 2020 FY | -9.52 Million CAD | 74.83% |
| 2020 Q4 | -9.52 Million CAD | 25.85% |
| 2020 Q3 | -12.84 Million CAD | 34.37% |
| 2020 Q2 | -19.56 Million CAD | 25.05% |
| 2019 Q2 | -55.85 Million CAD | 19.33% |
| 2019 Q1 | -69.23 Million CAD | 11.39% |
| 2019 Q4 | -37.83 Million CAD | 22.89% |
| 2019 FY | -37.83 Million CAD | -10.12% |
| 2019 Q3 | -49.06 Million CAD | 12.14% |
| 2018 Q1 | -51.6 Million CAD | -666.72% |
| 2018 Q4 | -78.13 Million CAD | -127.4% |
| 2018 FY | -34.35 Million CAD | -4463.89% |
| 2018 Q3 | -34.35 Million CAD | 21.75% |
| 2018 Q2 | -43.9 Million CAD | 14.91% |
| 2017 Q3 | -752.84 Thousand CAD | 74.32% |
| 2017 Q1 | -113.88 Thousand CAD | 25.98% |
| 2017 FY | -752.84 Thousand CAD | -1210.23% |
| 2017 Q4 | -6.73 Million CAD | -794.03% |
| 2017 Q2 | -2.93 Million CAD | -2474.21% |
| 2016 Q3 | 112.65 Thousand CAD | 134.69% |
| 2016 Q1 | -1.1 Million CAD | -5113.96% |
| 2016 Q4 | -153.85 Thousand CAD | -236.58% |
| 2016 Q2 | -324.7 Thousand CAD | 70.54% |
| 2016 FY | -57.45 Thousand CAD | 65.94% |
| 2015 Q2 | -21.09 Thousand CAD | -15.36% |
| 2015 Q1 | -18.28 Thousand CAD | 69.22% |
| 2015 FY | -168.69 Thousand CAD | -822.56% |
| 2015 Q4 | -21.13 Thousand CAD | -106.65% |
| 2015 Q3 | -10.22 Thousand CAD | 51.51% |
| 2014 Q4 | -59.4 Thousand CAD | 53.63% |
| 2014 FY | -18.28 Thousand CAD | 89.11% |
| 2014 Q3 | -128.1 Thousand CAD | -2.26% |
| 2014 Q2 | -125.27 Thousand CAD | 25.37% |
| 2014 Q1 | -167.86 Thousand CAD | 42.66% |
| 2013 Q2 | -457.29 Thousand CAD | -49.06% |
| 2013 Q3 | -337.83 Thousand CAD | 26.12% |
| 2013 Q4 | -292.73 Thousand CAD | 13.35% |
| 2013 FY | -167.86 Thousand CAD | 45.28% |
| 2013 Q1 | -306.79 Thousand CAD | 8.09% |
| 2012 Q4 | -333.81 Thousand CAD | 23.09% |
| 2012 FY | -306.79 Thousand CAD | 59.81% |
| 2012 Q2 | -518.42 Thousand CAD | 32.08% |
| 2012 Q1 | -763.3 Thousand CAD | 46.77% |
| 2012 Q3 | -434.04 Thousand CAD | 16.28% |
| 2011 Q1 | -530.68 Thousand CAD | -2.93% |
| 2011 Q4 | -1.43 Million CAD | 16.16% |
| 2011 Q3 | -1.71 Million CAD | 12.21% |
| 2011 Q2 | -1.94 Million CAD | -267.08% |
| 2011 FY | -763.3 Thousand CAD | -43.84% |
| 2010 Q1 | -297.11 Thousand CAD | -13.86% |
| 2010 Q3 | -698.78 Thousand CAD | -462.95% |
| 2010 Q4 | -515.59 Thousand CAD | 26.22% |
| 2010 FY | -530.68 Thousand CAD | -78.61% |
| 2010 Q2 | -124.12 Thousand CAD | 58.22% |
| 2009 Q1 | -55.83 Thousand CAD | 0.0% |
| 2009 Q4 | -260.95 Thousand CAD | 0.0% |
| 2009 FY | -297.11 Thousand CAD | -432.16% |
| 2008 FY | -55.83 Thousand CAD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Aequus Pharmaceuticals Inc. | 4.89 Million CAD | 103.844% |
| CanadaBis Capital Inc. | 4.08 Million CAD | 104.606% |
| Decibel Cannabis Company Inc. | 37.48 Million CAD | 100.502% |
| Delivra Health Brands Inc. | -2.17 Million CAD | 91.342% |
| Entourage Health Corp. | 150.32 Million CAD | 100.125% |
| Cannara Biotech Inc. | 41.51 Million CAD | 100.453% |
| Medicure Inc. | -5.82 Million CAD | 96.77% |
| PharmaCielo Ltd. | 18.24 Million CAD | 101.031% |
| Rubicon Organics Inc. | 475.37 Thousand CAD | 139.575% |
| BioSyent Inc. | -3.68 Million CAD | 94.895% |
| Voyageur Pharmaceuticals Ltd. | 37.91 Thousand CAD | 596.186% |